TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
0.4400
+0.0400 (10.00%)
Apr 25, 2025, 12:37 PM EDT - Market open

TransCode Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
1024933-
Upgrade
Market Cap Growth
-43.27%-43.27%-52.59%-73.34%--
Upgrade
Enterprise Value
61-3-010-
Upgrade
Last Close Price
0.403.37217.5417767.1967055.98-
Upgrade
PB Ratio
-5.67-1.162.522.691.60-
Upgrade
P/TBV Ratio
--2.522.691.60-
Upgrade
Debt / Equity Ratio
-0.02-0.020.28---0.61
Upgrade
Quick Ratio
2.102.100.791.158.222.05
Upgrade
Current Ratio
2.562.561.281.708.972.05
Upgrade
Return on Equity (ROE)
---759.85%-148.57%-80.53%-
Upgrade
Return on Assets (ROA)
-157.06%-157.06%-190.26%-76.30%-32.05%-72.09%
Upgrade
Return on Capital (ROIC)
-17645.14%-17645.14%-455.23%-98.51%-40.29%-
Upgrade
Earnings Yield
-146.49%-714.08%-448.40%-201.35%-20.91%-
Upgrade
FCF Yield
-116.79%-569.29%-437.86%-181.84%-16.87%-
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q